Literature DB >> 10871303

Chronic oral administration of ATP modulates nucleoside transport and purine metabolism in rats.

K Kichenin1, M Seman.   

Abstract

The effect of repeated oral administration of ATP on purine transport and metabolism was investigated in rats. An increased ability of the gut to capture intraluminal purine nucleosides and to export ATP and nucleosides toward portal bloodstream was observed in rats after 30 days of treatment with 5 mg/kg/day ATP. This was accompanied in erythrocytes by an increased transport of adenosine rapidly transformed into ATP, which in turn was exported toward extracellular fluid. However, these metabolic changes were associated with a paradoxical and progressive diminution of plasma ATP level below that found in control rats and that was not strictly dependent on the ATP dose administered, whereas plasma adenosine concentration remained unchanged. This diminution likely resulted from an increased ectonucleotidase activity, suggesting that the chronic administration of ATP seems to induce a progressive adaptation of purine metabolism. This adaptive response to free purine supplementation affects both intracellular metabolism and purine exchange between intracellular and extracellular compartments. This modification of free purine turnover and delivery may affect physiological parameters under the control of P(1) and P(2) purinoceptors described in different experimental models.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871303

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines.

Authors:  Eliezer Rapaport; Anna Salikhova; Edward H Abraham
Journal:  Purinergic Signal       Date:  2015-04-29       Impact factor: 3.765

2.  Adenosine 5'-triphosphate (ATP) supplements are not orally bioavailable: a randomized, placebo-controlled cross-over trial in healthy humans.

Authors:  Ilja Cw Arts; Erik Jcm Coolen; Martijn Jl Bours; Nathalie Huyghebaert; Martien A Cohen Stuart; Aalt Bast; Pieter C Dagnelie
Journal:  J Int Soc Sports Nutr       Date:  2012-04-17       Impact factor: 5.150

3.  Effects of oral adenosine-5'-triphosphate supplementation on athletic performance, skeletal muscle hypertrophy and recovery in resistance-trained men.

Authors:  Jacob M Wilson; Jordan M Joy; Ryan P Lowery; Michael D Roberts; Christopher M Lockwood; Anssi H Manninen; John C Fuller; Eduardo O De Souza; Shawn M Baier; Stephanie Mc Wilson; John A Rathmacher
Journal:  Nutr Metab (Lond)       Date:  2013-09-22       Impact factor: 4.169

4.  Adenosine-5'-triphosphate (ATP) supplementation improves low peak muscle torque and torque fatigue during repeated high intensity exercise sets.

Authors:  John A Rathmacher; John C Fuller; Shawn M Baier; Naji N Abumrad; Hector F Angus; Rick L Sharp
Journal:  J Int Soc Sports Nutr       Date:  2012-10-09       Impact factor: 5.150

5.  Effects of a supplement designed to increase ATP levels on muscle strength, power output, and endurance.

Authors:  Trent J Herda; Eric D Ryan; Jeffrey R Stout; Joel T Cramer
Journal:  J Int Soc Sports Nutr       Date:  2008-01-29       Impact factor: 5.150

6.  Oral adenosine-5'-triphosphate (ATP) administration increases blood flow following exercise in animals and humans.

Authors:  Ralf Jäger; Michael D Roberts; Ryan P Lowery; Jordan M Joy; Clayton L Cruthirds; Christopher M Lockwood; John A Rathmacher; Martin Purpura; Jacob M Wilson
Journal:  J Int Soc Sports Nutr       Date:  2014-06-13       Impact factor: 5.150

7.  Oral adenosine 5'-triphosphate supplementation improved hemodynamic and autonomic parameters after exercise in hypertensive women.

Authors:  Marcelo Conrado de Freitas; Ana Laura Ricci-Vitor; Renan Valero Freire; Erico Chagas Caperuto; Luiz Carlos Marques Vanderlei; Fábio Santos Lira; Fabrício Eduardo Rossi
Journal:  J Exerc Rehabil       Date:  2018-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.